AAAAAA
Results:
1-20
|
Results: 20
Authors:
Dogne, JM
de Leval, X
Delarge, J
Masereel, B
Citation: Jm. Dogne et al., Recent developments of thromboxane modulators, EXPERT OP T, 11(11), 2001, pp. 1663-1675
Authors:
Michaux, C
Rolin, S
Dogne, JM
Durant, F
Masereel, B
Delarge, J
Wouters, J
Citation: C. Michaux et al., Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition, BIOORG MED, 11(8), 2001, pp. 1019-1022
Authors:
Rolin, S
Dogne, JM
Michaux, C
Delarge, J
Masereel, B
Citation: S. Rolin et al., Activity of a novel dual thromboxane A(2) receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles, PROS LEUK E, 65(2), 2001, pp. 67-72
Authors:
de Leval, X
Delarge, J
Devel, P
Neven, P
Michaux, C
Masereel, B
Pirotte, B
David, JL
Henrotin, Y
Dogne, JM
Citation: X. De Leval et al., Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood, PROS LEUK E, 64(4-5), 2001, pp. 211-216
Authors:
Rogister, F
Laeckmann, D
Plasman, PO
Van Eylen, F
Ghyoot, M
Maggetto, C
Liegeois, JF
Geczy, J
Herchuelz, A
Delarge, J
Masereel, B
Citation: F. Rogister et al., Novel inhibitors of the sodium-calcium exchanger: benzene ring analogues of N-guanidino substituted amiloride derivatives, EUR J MED C, 36(7-8), 2001, pp. 597-614
Authors:
Dogne, JM
Wouters, J
Rolin, S
Michaux, C
Pochet, L
Durant, F
Delarge, J
Masereel, B
Citation: Jm. Dogne et al., Design, synthesis and biological evaluation of a sulfonylcyanoguanidine asthromboxane A(2) receptor antagonist and thromboxane synthase inhibitor, J PHARM PHA, 53(5), 2001, pp. 669-680
Authors:
Debuigne, F
Cuisenaire, J
Jeunieau, L
Masereel, B
Nagy, JB
Citation: F. Debuigne et al., Synthesis of nimesulide nanoparticles in the microemulsion Epikuron/isopropyl myristate/water/n-butanol (or isopropanol), J COLL I SC, 243(1), 2001, pp. 90-101
Authors:
Pochet, L
Doucet, C
Dive, G
Wouters, J
Masereel, B
Reboud-Ravaux, M
Pirotte, B
Citation: L. Pochet et al., Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsinand human leukocyte elastase, BIO MED CH, 8(6), 2000, pp. 1489-1501
Authors:
Dogne, JM
de Leval, X
Neven, P
Rolin, S
Wauters, J
David, JL
Delarge, J
Masereel, B
Citation: Jm. Dogne et al., Effects of a novel non-carboxylic thromboxane A(2) receptor antagonist (BM-531) derived from torasemide on platelet function, PROS LEUK E, 62(5), 2000, pp. 311-317
Authors:
Dogne, JM
de Leval, X
Delarge, J
David, JL
Masereel, B
Citation: Jm. Dogne et al., New trends in thromboxane and prostacyclin modulators, CURR MED CH, 7(6), 2000, pp. 609-628
Authors:
Wouters, J
Michaux, C
Durant, F
Dogne, JM
Delarge, J
Masereel, B
Citation: J. Wouters et al., Isosterism among analogues of torasemide: conformational, electronic and lipophilic properties, EUR J MED C, 35(10), 2000, pp. 923-929
Authors:
Michaux, C
Norberg, B
Dogne, JM
Durant, F
Masereel, B
Delarge, J
Wouters, J
Citation: C. Michaux et al., Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition, ACT CRYST C, 56, 2000, pp. 1265-1266
Authors:
Wouters, J
Durant, F
Masereel, B
Citation: J. Wouters et al., Antagonism of the TXA2 receptor by seratrodast: A structural approach, BIOORG MED, 9(19), 1999, pp. 2867-2870
Authors:
Lacan, F
Varache-Lembege, M
Vercauteren, J
Leger, JM
Masereel, B
Dogne, JM
Nuhrich, A
Citation: F. Lacan et al., Synthesis, structural characterization and thromboxane A(2) receptor antagonistic activity of 3-substituted 2-[(arylsulfonyl)imino]-2,3-dihydrothiazolyl derivatives, EUR J MED C, 34(4), 1999, pp. 311-328
Authors:
Golstein, PE
Boom, A
van Geffel, J
Jacobs, P
Masereel, B
Beauwens, R
Citation: Pe. Golstein et al., P-glycoprotein inhibition by glibenclamide and related compounds, PFLUG ARCH, 437(5), 1999, pp. 652-660
Authors:
Baudelet, C
Demeure, R
Frois, A
Masereel, B
Goudemant, JF
Ritter, C
Gallez, B
Citation: C. Baudelet et al., Evidence for a neuroprotective effect of pyrid-3-yl-sulphonylurea in photochemically induced focal ischaemia in rats: Magnetic resonance imaging evaluation, J PHARM PHA, 51(8), 1999, pp. 967-970
Authors:
Masereel, B
Damas, J
Fontaine, J
Lembege, M
Lacan, F
Nuhrich, A
Delarge, J
Pochet, L
Dogne, JM
Citation: B. Masereel et al., Thromboxane A(2) receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500), J PHARM PHA, 51(6), 1999, pp. 695-701
Authors:
Ouedraogo, R
Nguyen, QA
Kane, MHAC
Dunne, MJ
Pochet, L
Masereel, B
Lebrun, P
Citation: R. Ouedraogo et al., Insulinotropic effect of new glibenclamide isosteres, J PHARM EXP, 289(2), 1999, pp. 625-631
Authors:
Masereel, B
Michiels, G
Citation: B. Masereel et G. Michiels, Persistent Mullerian Duct Syndrome with torsion of an intra-abdominal seminoma, ACT CHIR B, 99(5), 1999, pp. 256-259
Authors:
Pirotte, B
de Tullio, P
Podona, T
Diouf, O
Dewalque, D
Neven, P
Masereel, B
Caignard, DH
Renard, P
Delarge, J
Citation: B. Pirotte et al., Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin gastrin receptor ligands: synthesis and biological evaluation, EUR J PH SC, 7(1), 1998, pp. 29-40
Risultati:
1-20
|